Connect with us

Health

Johnson & Johnson stop production of Covid-19 vaccine; what it may signal

Published

on

By Dana Malcolm

Staff Writer

 

February 16, 2022 – Johnson & Johnson has officially halted production at all of its Covid-19 vaccine producing facilities; this comes after last week’s announcement that some production would be stopped for the pharmaceutical company to shift focus to a new vaccine, unrelated to Covid-19.

The move comes as vaccination drives slow in higher income countries especially those in Europe and they begin to cancel Covid-19 restrictions.

Johnson & Johnson said, “We strive to improve human health and have worked tirelessly to … build a global manufacturing network across four continents to produce our COVID-19 vaccine. Our manufacturing sites produce multiple products as we have an obligation to supply life changing medicines to patients around the world and bring forward our innovative pipeline of new medicines and vaccines. We manage our production planning accordingly and are currently supplying from our extensive global network based on the demand for our vaccine and the needs of our patients and customers.”

The pharmaceutical company announced on February 8 that the plant would cease COVID19 operations temporarily to work on another vaccine for a different virus The New York Times reports.

The move prompted immediate fears from organizations like COVAX  and the African Union which depends on the Johnson & Johnson vaccine to meet their quotas and distribute the vaccines to poorer countries worldwide.

Despite the controversy surrounding the vaccine and its effects in relation to blood clotting Johnson & Johnson has been one of the most distributed brands in the world.

The company has said that they supply based on the needs of patients and customers but only 54 per cent of the world has been fully vaccinated against COVID-19 so far. Notable is the staggering unevenness of the vaccination: only 11 per cent of the population has received one dose of a vaccine in low income countries.  Conversely, high income countries have successfully vaccinated over 78 per cent of their populations.

Johnson & Johnson is currently in use in 82 different countries worldwide.

This begs the question of why Johnson & Johnson is stopping production when there are so many persons in lower income countries especially still depending on its vaccine

The NY Times also reports that neither COVAX or The African Union were informed of the decision by Johnson & Johnson beforehand.

The African Union said, “This is not the time to be switching production lines of anything, when the lives of people across the developing world hang in the balance.”

COVAX expressed similar sentiments. They said that Johnson & Johnson had already let them down in 2021 and they couldn’t of the word to be let down in 2022.

In response J&J said “We are focused on ensuring our vaccine is available where people are in need, and we continue to fulfill our contractual obligations in relation to the COVAX Facility and the African Union, we currently have millions of doses of our COVID-19 vaccine in inventory.”

Johnson & Johnson struggled with vaccines expiring before they were able to be used early in production. The FDA extended the expiry dates in July last year from the initial four and a half months.

The vaccines currently have a shelf life of six months.

Health

Bruce Willis’ Brave Gift to Dementia Research – And His now Quiet Link to Turks & Caicos

Published

on

December 4, 2025 – Hollywood legend Bruce Willis – arguably the most famous former home owner in Turks and Caicos Islands – is facing the most difficult role of his life and turning it into one last act of service.

Willis, 70, retired from acting in 2022 after his family revealed he had been diagnosed with aphasia. The following year, specialists confirmed he is living with frontotemporal dementia (FTD), a degenerative brain disease that attacks language, behaviour and personality.

In recent interviews and appearances, his wife Emma Heming Willis has said Bruce is “surrounded by love and care” and that the family is learning to find joy in new ways, even as the disease progresses.

Now, Heming Willis has gone further.  In her 2025 memoir The Unexpected Journey, she writes that the family has decided Bruce’s brain will be donated to science after his death to advance research into FTD.  That decision has been highlighted in recent coverage by futurist and science outlets, which describe it as a carefully considered step after months of watching a still-physically-strong man steadily lose speech, reading and independence.

Neurologists have long stressed how rare donated brain tissue is for FTD, and how essential it is to understanding which proteins, mutations and mechanisms are actually driving the disease.  The Willis family’s choice means the brain that powered some of cinema’s most iconic characters could one day help researchers diagnose the condition earlier and design better treatments – even if it cannot help Bruce himself.

For Turks and Caicos, the story lands close to home.  For nearly two decades Willis owned “The Residence” on exclusive Parrot Cay – a 7.3-acre, Asian-inspired beachfront compound with a five-bedroom main house, two guest villas and a yoga pavilion.  He and Emma listed the estate in March 2019 for US$33 million; it sold a few months later for about US$27 million, one of the biggest residential deals in TCI history.

So, while Bruce Willis no longer has a physical address in Turks and Caicos, his connection to these islands remains part of his global story – a story now shifting from blockbuster fame to medical legacy, as his family turns private heartbreak into a public contribution that could change what we know about dementia.

Developed by Deandrea Hamilton • with ChatGPT (AI) • edited by Magnetic Media.

Continue Reading

Health

From 54 New Cases in July to Zero in August: TCI’s COVID Turnaround

Published

on

Deandrea Hamilton | Editor

Turks and Caicos, September 6, 2025 – COVID-19 fears in the Turks and Caicos Islands that once had residents on edge are now giving way to a sense of relief. The Ministry of Health and Human Services reports a dramatic reversal: from dozens of new cases in July to zero cases and zero hospitalizations today.

Between August 17 and 23, 2025, officials confirmed no new cases, no hospitalizations, and no new deaths. Just two recoveries were recorded, bringing the national recovery tally to 6,866. The total confirmed cases since 2020 stand at 6,922, with deaths unchanged at 41. Health officials say August has been relatively quiet overall, with 19 new cases and recoveries recorded for the month — a fraction of what the islands faced just weeks earlier.

The contrast could not be sharper. The most concerning bulletin came in mid-July, when the Ministry reported 54 new cases in a single week. Ten were fresh positives, while the other 44 came from a backlog of April samples. At that time, two new hospitalizations were recorded, and the islands mourned one additional COVID-related death, bringing the total to 41. It was a sobering reminder that the virus was still circulating, pushing recoveries to 6,845 and raising the cumulative case count to 6,910. The July spike stirred fear among residents and renewed calls for vigilance, as community spread and delayed lab results painted a worrying picture.

Fast forward to late August, and the numbers tell a very different story. Not only are new cases negligible, but the hospitals are reporting no COVID-19 patients at all. Officials say testing continues across a wide range of categories, and the Ministry urges the public to stay cautious: wash hands, wear masks in crowded spaces, protect the vulnerable, and get vaccinated. But the tone now is one of optimism.

Since the pandemic began in 2020, Turks and Caicos has recorded nearly 7,000 cases in total, with 6,866 recoveries and 41 deaths. The islands’ small population means every case has felt significant, and surges like July’s were especially unsettling. But today’s figures suggest the country has reached a new stage: COVID-19 is no longer the disruptive force it was. The Ministry credits continued public vigilance and the accessibility of free testing and vaccines at government clinics. While the numbers are cause for celebration, health leaders are careful not to declare the fight over. The Ministry’s latest bulletin reminds residents to maintain hygienic practices, follow self-isolation guidelines if infected, and ensure vaccinations are up to date.

The pandemic may not be entirely behind the Turks and Caicos, but compared to the frightening figures of July, the near-zero landscape of August offers a powerful sign of hope.

The Ministry released the bulletin on September 2, confirming that for the week of August 17–23, no new cases, hospitalizations, or deaths were recorded — a sharp contrast to the surge just weeks earlier.

Continue Reading

Health

Turks and Caicos Islands Health Delegation Completes Strategic Visits to Florida and Cayman Islands to Advance Health Sector Reform and Strengthen Treatment Abroad Programme  

Published

on

MoHHS Team-Broward Health

Providenciales, Turks and Caicos Islands, 22 August 2025 — A high-level delegation from the Ministry of Health and Human Services (MOHHS) has successfully concluded strategic working visits to Florida and the Cayman Islands from August 5–13, 2025. The mission aimed to strengthen the Treatment Abroad Programme, explore innovative health system models, and advance the Turks and Caicos Islands’ health sector reform agenda through strategic regional partnerships.

Delegation Members:

  • Hon. Kyle Knowles – Minister of Health and Human Services

    MoHHS Team with Health City Executive Management Team

  • Mrs. Desiree Lewis – Permanent Secretary, Health and Human Services
  • Mr. Lynrod Brooks – Director, Health Policy and Planning
  • Ms. Florinda Talbot – Contract Performance Manager
  • Mrs. Romaine Missick-Smith – CEO, Health Regulations Authority
  • Ms. Jasmine Malcolm – Executive Administrator, MOHHS

Minister of Health and Human Services, Hon. Kyle Knowles, highlighted the significance of these engagements:

“These visits were not ceremonial; they were strategic, focused, and impactful. In Florida, we reinforced partnerships with leading healthcare providers to ensure TCI patients referred overseas receive the highest standards of clinical care and patient support. In the Cayman Islands, our mission was two-fold: to study the operations of the Cayman Islands Health Services Authority as a model to guide the establishment of our own Health Services Authority, and to strengthen ties with Cayman-based treatment partners, where many of our patients are referred under the Treatment Abroad Programme. Both visits underscored that small island states share many health challenges, and that collaboration, innovation, and adapting best practices to our local context are essential to achieving better health outcomes for our people.”

Florida – Strengthening the Treatment Abroad Programme

MoHHS Team with Cayman Minsterial officials

During the period August 5–9, the delegation visited Broward Medical Center, University of Miami Health System, Cleveland Clinic, Nicklaus Children’s Hospital, and the International Reinsurance Managers Network. They also toured REVA Air Ambulance Services to review medical evacuation operations and patient transfer management.                                                                                                                                                     Discussions centered on patient care pathways, specialized services in ophthalmology, cardiology, oncology, and pediatrics, family-centered care models, advanced telemedicine for pre- and post-treatment consultations, and reinsurance strategies for high-cost overseas cases. Key outcomes include agreements to expand telehealth consultations, develop a standardized referral package to reduce delays, explore reinsurance arrangements to safeguard public health budgets, and establish specialized pediatric transfer protocols.

Cayman Islands – Health Sector Reform and Treatment Abroad Partnerships
From August 10–13, the delegation engaged with senior executives at Health City Cayman Islands, including Dr. Binoy Chattuparambil (Clinical Director), Shomari Scott (Chief Business Development Officer), Rebecca Brooks (Head of Marketing and Sales), and Ingrid Harris (Sales and Marketing). The team toured two hospital facilities and held in-depth discussions with Lizzette Yearwood, Chief Executive Officer along with leadership staff of the Cayman Islands Health Services Authority

The focus was two-fold:

  1. Health Sector Reform – Examining governance, financial management, and operational structures of the Cayman Islands HSA model

    MoHHS Team with CEO and senior official Cayman HSA 

    to inform TCI’s development of its own Health Services Authority.

  2. Treatment Abroad Strengthening – Reviewing current referral arrangements with Cayman healthcare partners to enhance patient care coordination and improve treatment pathways for TCI patients referred to Cayman.

The delegation also met with Honourable Katherine Ebanks-Wilks, Minister for Health, Environment, Sustainability, and Honourable G. Wayne Panton, Parliamentary Secretary for Health. The team concluded with a meeting with Acting Premier Hon. Gary B. Rutty and Cabinet members, reaffirming the shared commitment to improving healthcare access and outcomes through regional collaboration.

Next Steps

The Ministry will incorporate lessons learned from these visits into ongoing health reform planning, ensuring that the proposed Health Services Authority is tailored to TCI’s needs while reflecting regional best practices. Efforts will continue to ensure that the Treatment Abroad Programme delivers efficient, sustainable, and patient-centered care.

Continue Reading

FIND US ON FACEBOOK

TRENDING